Skip to main content

Advertisement

SpringerLink
Log in

Prophylaxis for stress-related gastrointestinal hemorrhage

  • Published:
Current Treatment Options in Gastroenterology Aims and scope Submit manuscript

Opinion statement

The incidence of clinically important stress-related gastrointestinal hemorrhage (SRGIH) has decreased without the use of prophylaxis. This decline is probably attributable to improved care in the modern intensive care unit: aggressive correction of hypovolemia, adequate respiratory support, maintenance of tissue perfusion, and improved nutritional support. The majority of patients admitted to intensive care units are not at risk of developing clinically important SRGIH. Patients who are at high risk for SRGIH, and who may, therefore, benefit from prophylaxis, are those with at least one of the factors listed in Table 1. Antacids, histamine type 2-receptor antago-nists (H2 RA), proton pump inhibitors, and sucralfate all provide comparable protection from SRGIH. The choice of pharmacologic agent for prophylaxis therefore depends on other considerations, such as cost, side effects, and ease of administration. In this regard, it is still unclear whether these prophylactic medications increase the inci-dence of nosocomial pneumonia when administered to intensive care unit patients. Antacids may pose the greatest risk for developing pneumonia, followed by H2RA, and sucralfate. More research is necessary to resolve this important issue. Pharmacologic prophylaxis for SRGIH is cost effective only in high- risk populations. Based on existing literature, the cost of using of routine prophylaxis is prohibitive for at least two-thirds of patients admitted to intensive care units who are at low risk of SRGIH. When prophylaxis is administered to high-risk patients, the cost-per-averted-bleeding episode for sucralfate is lower than for other medications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Bresalier RS. The clinical significance and pathophysi-ology of stress-related gastric mucosal hemorrhage. J Clin Gastroenterol. 1991, 13(Suppl 2):S35-S42.

    PubMed  Google Scholar 

  2. Schuster DP, Rowley H, Feinsten S, et al. Prospective evaluation of the risk of upper gastrointestinal bleeding after admission to a medical intensive care unit. Am J Med. 1984, 76:623–630.

    Article  PubMed  CAS  Google Scholar 

  3. Ben-Menachem T, Fogel R, Patel RV, et al. Prophylaxis for stress-related gastric hemorrhage in the medical intensive care unit: A randomized, controlled, single-blind study. Ann Intern Med. 1994, 121:568–575. Large propective randomized trial of stress ulcer prophylaxis which includes a no-treatment group for comparison. Reviews the pitfalls of designing and interepreting such studies.

    PubMed  CAS  Google Scholar 

  4. Cook DJ, Fuller HD, Guyatt GH, et al. Risk factors for gastrointestinal bleeding in critically ill patients. N Engl J Med. 1994, 330:377–381. Evaluates the incidence of stress-related gastrointestinal hemor-rhage and impact of individual risk factors in the modern ICU.

    Article  PubMed  CAS  Google Scholar 

  5. Devlin JW, Ben-Menachem T, Ulep SK, et al. Stress ulcer prophylaxis in medical ICU patients: annual utilization in relation to the incidence of endoscopi-cally proven stress ulceration. Ann Pharmacother. 1998, 32:869–874.

    Article  PubMed  CAS  Google Scholar 

  6. Tryba M. Prophylaxis of stress ulcer bleeding, A Meta-Analysis. J Clin Gastroenterol. 1991, 13(Suppl 2):S44-S55.

    PubMed  Google Scholar 

  7. Cook DJ, Witt LG, Cook RJ, et al. Stress ulcer prophy-laxis in the critically ill: A meta-analysis. Am J Med. 1991, 91:519–527.

    Article  PubMed  CAS  Google Scholar 

  8. Peterson, WL. Prevention of upper gastrointestinal bleeding. N Engl J Med. 1994, 330:428–429.

    Article  PubMed  CAS  Google Scholar 

  9. Bresalier RS. Sucralfate for prevention of acute gastrointestinal bleeding. In Sucralfate: From Basic Science to Bedside. Edited by Holander D and Tytgat GNJ.New York: Plenum Press; 1995:289–301.

    Google Scholar 

  10. Cook D, Reeve BK, Guyatt GH et al. Stress ulcer prophy-laxis in critically ill patients. Resolving discordant meta-analyses. JAMA. 1996, 275:308–314. Meta-analysis which examines the efficacy of various agents for prevention of stress-related bleeding, and their impact on development of nosocomial pneumonia in the ICU.

    Article  PubMed  CAS  Google Scholar 

  11. Lacroix J, Infante-Rivard C, Jenicek M, et al. Prophylaxis of upper gastro-intestinal bleeding in intensive care units: A meta-analysis. Crit Care Med. 1989, 17:862–869.

    Article  PubMed  CAS  Google Scholar 

  12. Wilcox CM, Spenney JG. Stress ulcer prophylaxis in medical patients: Who, what and how much? Am J Gastroenterol. 1988, 83:1199–1211.

    PubMed  CAS  Google Scholar 

  13. Pinilla JC, Oleniuk FH, Reed D, et al. Does antacid prophylaxis prevent upper gastrointestinal bleeding in critically ill patients? Crit Care Med 1985, 13:646–650.

    Article  PubMed  CAS  Google Scholar 

  14. van den Berg B, van Blankenstein M. Prevention of stress-induced upper gastro-intestinal bleeding by cimetidine in patients on assisted ventilation. Digestion. 1985, 31:1–8.

    Article  PubMed  Google Scholar 

  15. Peura DA, Johnson LF. Cimetidine for prevention and treatment of gastroduodenal mucosal lesions in patients in an intensive care unit. Ann Intern Med. 1985, 103:173–177.

    PubMed  CAS  Google Scholar 

  16. Lacroix J, Infant-Rivard C, Gauthier M, et al.. Upper gastrointestinal tract bleeding acquired in a pediatric intensive care unit: Prophylaxis trial with cimetidine. J Pediatr. 1986, 108:1015–1018.

    Article  PubMed  CAS  Google Scholar 

  17. Groll A, Simon JB, Wigle RD, et al.. Cimetidine prophy-laxis for gastrointestinal bleeding in an intensive care unit. Gut. 1986, 27:135–140.

    PubMed  CAS  Google Scholar 

  18. Karlstadt RG, Iberti TJ, Silverstein J, et al. Comparison of cimetidine and placebo for the prophylaxis of upper gastro-intestinal bleeding due to stress-related gastric mucosal damage in the intensive care unit. J Intensive Care Med. 1990, 5:26–32.

    Google Scholar 

  19. Reusser P, Gyr K, Scheidegger D, et al. Prospective endoscopic study of stress erosions and ulcers in critically ill neurosurgical patients: Current incidence and effect of acid-reducing prophylaxis. Crit Care Med. 1990, 18:270–273.

    Article  PubMed  CAS  Google Scholar 

  20. Ruiz-Santana S, Ortiz E, Gonzalez B, et al. Stress-induced gastroduodenal lesions and total parenteral nutrition in critically ill patients: Frequency, compli-cations, and the value of prophylactic treatment. A prospective, randomized study. Crit Care Med. 1991, 19:887–891.

    Article  PubMed  CAS  Google Scholar 

  21. Cook DJ, Pearl RG, Cook RJ, et al. The incidence of clinically important bleeding in ventilated patients. J Intensive Care Med. 1991, 6:167–174.

    Google Scholar 

  22. Lacroix J, Nadeau D, Laberge S, et al. Frequency of upper gastrointestinal bleeding in a pediatric intensive care unit. Crit Care Med. 1992, 20:35–42.

    Article  PubMed  CAS  Google Scholar 

  23. Cochran EB, Phelps SJ, Tolley EA, et al. Prevalence of, and risk factors for, upper gastrointestinal tract bleeding in critically ill pediatric patients. Crit Care Med. 1992, 20:1519–1523.

    Article  PubMed  CAS  Google Scholar 

  24. Martin LF, Booth FV, Karlstadt RG et al. Continuous intravenous cimetidine decreases stress-related upper gastrointestinal hemorrhage without promoting pneumonia. Crit Care Med. 1993, 21:19–30.

    Article  PubMed  CAS  Google Scholar 

  25. Pingleton SK, Hadzima SK. Enteral alimentation and gastrointestinal bleeding in mechanically ventilated patients. Crit Care Med. 1983, 11:13–17.

    Article  PubMed  CAS  Google Scholar 

  26. Zandstra DF, Stoutenbeck CP. The virtual absence of stress-related bleeding in ICU patients receiving prolonged mechanical ventilation without any prophylaxis. A prospective cohort study. Intensive Care Med 1994, 20:335–340.

    Article  PubMed  CAS  Google Scholar 

  27. Driks MR, Craven DE, Celli BR, et al. Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. N Engl J Med. 1987, 317:1376–1382.

    Article  PubMed  CAS  Google Scholar 

  28. Ben-Menachem T, McCarthy BD, Fogel R et. al.Prophylaxis for stress-related gastrointestinal hemor-rhage: A cost effectiveness analysis. Crit Care Med 1996, 24:338–345. Cost effectiveness analysis which highlights the importance of determining the incidence of stress-related hemorrhage in different ICU populations and the risk of nosocomial pneu-monia for the agents prescribed as prophylaxis. Methodology of the analysis is described in detail, allowing the reader to experiment with assumptions which may differ from those used by the authors.

    Article  PubMed  CAS  Google Scholar 

  29. Craven DE, Kunches LM, Kilinsky V, et al. Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis. 1986, 133:792–796.

    PubMed  CAS  Google Scholar 

  30. Reusser P, Zimmerli W, Scheidegger D, et al. Role of gastric colonization in nosocomial infections and endotoxemia: a prospective study in neurosurgical patients on mechanical ventilation. J Infect Dis. 1989, 160:414–421.

    PubMed  CAS  Google Scholar 

  31. Cook D, Guyatt G, Marshall J, et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechan-ical ventilation. N Engl J Med. 1998, 339:791–797.

    Article  Google Scholar 

  32. Phillips JO, Metzler MH, Palmieri TL, et al. A prospec-tive study of simplified omeprazole suspension for the prophylaxis of stress-related mucsosal damage. Crit Care Med. 1996, 24:1793–1800.

    Article  PubMed  CAS  Google Scholar 

  33. Lasky MR, Metzler MH, Phillips JO. A prospective study of omeprazole suspension to prevent clinically significant gastrointestinal bleeding from stress ulcers in mechanically ventilated patients. J Trauma. 1998, 44:527–533.

    Article  PubMed  CAS  Google Scholar 

  34. Skala I, Mareckova O, Vitko S, et al. Prophylaxis of acute gastroduodenal bleeding after renal trans-plantation. Transpl Int. 1997, 10:375–378.

    Article  PubMed  CAS  Google Scholar 

  35. Barie PS, Hariri RJ. Therapeutic use of omeprazole for refactory stress-induced gastric mucosal hemorrhage. Crit Care Med. 1992, 20:899–901.

    Article  PubMed  CAS  Google Scholar 

  36. MacDougall BRD, Bailey RJ, Williams R. H 2 -receptor antagonists and antacids in the prevention of acute gas-trointestinal haemorrhage in fulminant hepatic failure: two controlled trials. Lancet. 1977, 1:617–619.

    Article  PubMed  CAS  Google Scholar 

  37. Hastings PR, Skillman JJ, Bushnell LS, et al. Antacid titration in the prevention of acute gastrointestinal bleeding. N Engl J Med. 1978, 298:1041–1045.

    Article  PubMed  CAS  Google Scholar 

  38. Zinner MJ, Zuidema GD, Smith Pl et. al. The prevention of upper gastrointestinal tract bleeding in an inten-sive care unit. Surg Gynecol Obstet 1981, 153:214–220.

    PubMed  CAS  Google Scholar 

  39. Bresalier RS, Grendell JH, Cello JP, et al.: Sucralfate suspension versus titrated antacid for the prevention of stress-related gastrointestinal hemorrhage in critically ill patients. Amer J Med 1987, 83(Suppl 38):110–116.

    Article  PubMed  CAS  Google Scholar 

  40. Ohta S, Yukioka T, Ohta S, et al. Hemostasis with Endo-scopic hemoclipping for severe gastrointestinal bleed-ing in critically ill patients. Am J Gastroenterol. 1996, 91:701–704.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Gastroenterology Department, Henry Ford Health Sciences Center, 48202, Detroit, MI

    Tamir Ben-Menachem MD, MS & Robert S. Bresalier MD

Authors
  1. Tamir Ben-Menachem MD, MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert S. Bresalier MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ben-Menachem, T., Bresalier, R.S. Prophylaxis for stress-related gastrointestinal hemorrhage. Curr Treat Options Gastro 2, 313–319 (1999). https://doi.org/10.1007/s11938-999-0009-2

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11938-999-0009-2

Keywords

Search

Navigation